Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome

Metabolic Syndrome and Related Disorders

Volumn 8, Issue 3, 2010, Pages 229-234

  Aydin, Hasan ^a   Toprak, Ahmet ^b   Deyneli, Oǧuzhan ^b   Yazici, Dilek ^c   Tarççin, Özlem ^d   Sancak, Seda ^b   Yavuz, Dilek ^b   Akalin, Sema ^b  

^a YEDITEPE UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c FSM Teaching and Research Hospital   (Turkey)

^d Siyami Ersek Cardiovascular Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADIPOSE TISSUE; ADULT; ARTERY DILATATION; ARTICLE; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ENDOTHELIAL DYSFUNCTION; EPICARDIAL FAT TISSUE THICKNESS; EPICARDIUM; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; M MODE ECHOCARDIOGRAPHY; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADIPOSE TISSUE; ADIPOSITY; ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERICARDIUM; RISK ASSESSMENT; RISK FACTORS; TURKEY; ULTRASONOGRAPHY, DOPPLER; VASODILATION; YOUNG ADULT;

EID: 77953800145     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2009.0080     Document Type: Article

References (28)

1. Cox BD, Whichelow MJ, Prevost AT. The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults. Int J Obes Relat Metab Disord 1998;22:966-973.
2. Wall RT, Rubenstein MD, Cooper SL. Studies on the cellular basis of atherosclerosis: the effects of atherosclerosis risk factors on platelets and the vascular endothelium. Diabetes 1981;30:39-43.
3. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfi eld JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-1474.
4. Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, Bosello O, Lechi A. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999;23:936-942.
5. Vigili de Kreutzenberg S, Kiwanuka E, Tiengo A, Avogaro A. Visceral obesity is characterized by impaired nitric oxide-independent vasodilation. Eur Heart J 2003;24:1210-1215.
6. Macor C, Ruggeri A, Mazzonetto P, Federspil G, Cobelli C, Vettor R. Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity. Metabolism 1997;46:123-129.
7. Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, Islam AH, Keno Y, Kobatake T, Nagai Y, Fujioka S, Tarui S, Matsuzawa Y. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994;107:239-246.
8. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F. Epicardial fat from echocardiography: A new method for visceral adipose tissue prediction. Obes Res 2003;11:304-310.
9. Singh N, Singh H, Khanijoun HK, Iacobellis G. Echocardiographic assessment of epicardial adipose tissue-a marker of visceral adiposity. McGill J Med 2007;10:26-30.
10. Malavazos AE, Ermetici F, Coman C, Corsi MM, Morricone L, Ambrosi B. Infl uence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity. Int J Cardiol 2007;121:132-134.
11. Iacobellis G, Sharma AM. Epicardial adipose tissue as new cardio- metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr Pharm Des 2007;13:2180-2184.
12. de Vos AM, Prokop M, Roos CJ, Meijs MF, van der Schouw YT, Rutten A, Gorter PM, Cramer MJ, Doevendans PA, Rensing BJ, Bartelink ML, Velthuis BK, Mosterd A, Bots ML. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcifi cation in post-menopausal women. Eur Heart J 2008;29:777-783.
13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JJA, Costa F. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute Scientifi c Statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
14. Celermajer DC, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
15. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: A new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003;88:5163-5168.
16. Demerath EW, Reed D, Rogers N, Sun SS, Lee M, Choh AC, Couch W, Czerwinski SA, Chumlea WC, Siervogel RM, Towne B. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr 2008;88:1263-1271.
17. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-2610.
18. Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 2004;53:1671-1679.
19. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2004;86:1930-1935.
20. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V. Association of low adiponectin levels with the metabolic syndrome-the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005;54:476-481.
21. Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, McTernan PG. Human epicardial adipose tissue expresses a pathogenic profi le of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006;5:1.
22. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, Gallo P, di Gioia CR. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005;29:251-255.
23. Iacobellis G, Tiziana di Gioia CR, Cotesta D, Petramala L, Travaglini C, De Santis V, Vitale D, Tritapepe L, Letizia C. Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels. Horm Metab Res 2009;41: 227-231.
24. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C. The implication of obesity and central fat on markers of chronic infl ammation: The ATTICA study. Atherosclerosis 2005;183:308-315.
25. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y. Human epicardial adipose tissue is a source of infl ammatory mediators. Circulation 2003;108:2460-2466.
26. Zhang H, Chen X, Aravindakshan J, Sairam MR. Changes in adiponectin and infl ammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: implications for insulin resistance. Endocrinology 2007;148:5667-5679.
27. Thompson A, Danesh J. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: A literature-based meta-analysis of prospective studies. J Int Med 2006;259:481-492.
28. Waldius G, Jungner I. The apoB/apoA-I ratio: A strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Int Med 2006;259:493-519.